Hop til indhold
Knowledge bank

Find your way in the ATMP landscape

ATMP Denmark is building a shared knowledge bank that supports overview, understanding, and collaboration across.

On the way toward a comprehensive overview

ATMP Denmark is working to create a comprehensive national overview of the field of advanced therapies, including cell therapy, gene therapy, and tissue-engineered medicinal products.

As part of this work, a knowledge bank and a map are being developed to make it easier for professionals, decision-makers, research environments, authorities, and companies to find relevant knowledge, stakeholders, and infrastructure in the ATMP field.

The content will be developed continuously in dialogue with relevant stakeholders and updated as the field matures.

Knowledge Bank

Knowledge bank on the way

The knowledge bank brings together key information, experience, and resources about ATMPs in Denmark and internationally. The purpose is to make complex knowledge more accessible and support a shared understanding across the healthcare system, research, authorities, and industry.

The knowledge bank may, among other things, contain information on regulatory frameworks, clinical use, production, quality, organisation, and implementation of ATMPs in the healthcare system.

In addition, the knowledge bank shares selected questions and answers from, for example, the Danish Medicines Agency, as well as experiences from ATMP Denmark’s regulatory support. This is intended to make it easier for stakeholders in the field to navigate recurring regulatory issues and gain access to general knowledge about requirements, processes, and relevant dialogue with regulatory authorities.

Map

Overview: The ATMP landscape in Denmark

A new map will make knowledge, capacity, and collaborations within advanced therapy medicinal products visible and form the basis for better coordination and joint development.

The map should provide a visual and structured overview of the Danish ATMP landscape. It may include relevant stakeholders, research and treatment environments, clinical trials, infrastructure, production capacity, competencies, and areas of collaboration.

The aim is to make it easier to see where knowledge, capacity, and experience already exist - and where there is a need for development, coordination, or new collaborations.

pexels-mak_-jp-107017486-9859746.jpg